The American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) released the TNM Classification of Malignancies, 8th Edition, on 1 January 2018, dividing oropharyngeal cancer into p16-positive and p16-negative tumors [6]. This evidence concerns the gene CDKN2A and oropharynx cancer.